Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome–Negative B-Precursor ALL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL
J. Clin. Oncol 2023 Oct 26;[EPub Ahead of Print], M Stelljes, S Raffel, N Alakel, R Wäsch, M Kondakci, S Scholl, A Rank, M Hänel, B Spriewald, M Hanoun, S Martin, K Schwab, H Serve, L Reiser, J Knaden, H Pfeifer, J Marx, T Sauer, WE Berdel, G Lenz, M Brüggemann, N Gökbuget, K WethmarFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.